Hospital Corporation of China Yönetim

Yönetim kriter kontrolleri 2/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Shuai Chen

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	4.4yrs
CEO sahipliği	n/a
Yönetim ortalama görev süresi	3.7yrs
Yönetim Kurulu ortalama görev süresi	6.1yrs

Son yönetim güncellemeleri

Recent updates

We Think Hospital Corporation of China (HKG:3869) Can Stay On Top Of Its Debt

Oct 01

Not Many Are Piling Into Hospital Corporation of China Limited (HKG:3869) Stock Yet As It Plummets 28%

Aug 30

We Think Hospital Corporation of China's (HKG:3869) Profit Is Only A Baseline For What They Can Achieve

Apr 29

Hospital Corporation of China Limited (HKG:3869) Stock Rockets 33% But Many Are Still Ignoring The Company

Jun 30

Hospital Corporation of China (HKG:3869) Hasn't Managed To Accelerate Its Returns

May 17

Does Hospital Corporation of China (HKG:3869) Have A Healthy Balance Sheet?

Apr 12

Would Shareholders Who Purchased Hospital Corporation of China's (HKG:3869) Stock Three Years Be Happy With The Share price Today?

Mar 08

Should You Be Impressed By Hospital Corporation of China's (HKG:3869) Returns on Capital?

Jan 14

Hospital Corporation of China (HKG:3869) Takes On Some Risk With Its Use Of Debt

Dec 10

CEO

Shuai Chen (50 yo)

4.4yrs

Görev süresi

Mr. Shuai Chen has been an Acting Chief Executive Officer at Hospital Corporation of China Limited since June 23, 2020 and its Executive Director since November 20, 2020. He served as Director at I-Mab sin...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Shuai Chen	Executive Chairman & Acting CEO	4.4yrs	Veri yok	Veri yok
Jianli Pan	Executive Director & CFO	3.6yrs	CN¥1.81m	Veri yok
Chengchuan Pu	Executive Director	3.4yrs	Veri yok	Veri yok
Hui Liu	Assistant President	no data	Veri yok	Veri yok
Yuanzhi Wu	Executive Vice President	1.8yrs	Veri yok	Veri yok
Xiaofeng Lang	Chief Company Development Officer & Assistant to the Chairman	4.2yrs	Veri yok	Veri yok
Wing Yan Ho	Company Secretary	3.8yrs	Veri yok	Veri yok

3.7yrs

Ortalama Görev Süresi

43yo

Ortalama Yaş

Deneyimli Yönetim: 3869 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.7 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Shuai Chen	Executive Chairman & Acting CEO	4.4yrs	Veri yok	Veri yok
Jianli Pan	Executive Director & CFO	2.7yrs	CN¥1.81m	Veri yok
Chengchuan Pu	Executive Director	3.4yrs	Veri yok	Veri yok
Nan Wang	Non-Executive Director	7.5yrs	Veri yok	Veri yok
Luwen Shi	Independent Non-Executive Director	7.9yrs	CN¥150.00k	Veri yok
Xiangliang Zhou	Independent Non-Executive Director	7.9yrs	CN¥150.00k	Veri yok
Lu Liu	Non-Executive Director	7.5yrs	Veri yok	Veri yok
Jinxue Dang	Independent Non-Executive Director	4.7yrs	CN¥150.00k	Veri yok

6.1yrs

Ortalama Görev Süresi

49yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 3869 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6.1 yıldır).

Hospital Corporation of China Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

Hospital Corporation of China Limited, Annual General Meeting, Jun 20, 2024

Hospital Corporation of China Limited Announces Resignation of Lu Wenzuo as Executive Director

Less than half of directors are independent

Hospital Corporation of China Limited, Annual General Meeting, Jun 22, 2022

Less than half of directors are independent

Hospital Corporation of China Limited Announces Executive Changes

Recent updates

We Think Hospital Corporation of China (HKG:3869) Can Stay On Top Of Its Debt

First half 2024 earnings released: CN¥0.14 loss per share (vs CN¥0.91 profit in 1H 2023)

Not Many Are Piling Into Hospital Corporation of China Limited (HKG:3869) Stock Yet As It Plummets 28%

Hospital Corporation of China Limited to Report First Half, 2024 Results on Aug 29, 2024

New minor risk - Market cap size

We Think Hospital Corporation of China's (HKG:3869) Profit Is Only A Baseline For What They Can Achieve

Hospital Corporation of China Limited, Annual General Meeting, Jun 20, 2024

New major risk - Financial position

Full year 2023 earnings released: EPS: CN¥0.96 (vs CN¥3.48 loss in FY 2022)

Hospital Corporation of China Limited to Report Fiscal Year 2023 Results on Mar 26, 2024

Investor sentiment deteriorates as stock falls 22%

New minor risk - Share price stability

Investor sentiment improves as stock rises 26%

First half 2023 earnings released: EPS: CN¥0.91 (vs CN¥3.09 loss in 1H 2022)

Investor sentiment improves as stock rises 23%

First half 2023 earnings released: EPS: CN¥0.91 (vs CN¥3.08 loss in 1H 2022)

Hospital Corporation of China Limited to Report Q2, 2023 Results on Aug 30, 2023

New minor risk - Market cap size

Now 36% undervalued after recent price drop

New minor risk - Share price stability

Hospital Corporation of China Limited (HKG:3869) Stock Rockets 33% But Many Are Still Ignoring The Company

Full year 2022 earnings released: CN¥3.48 loss per share (vs CN¥2.03 loss in FY 2021)

Hospital Corporation of China Limited Announces Resignation of Lu Wenzuo as Executive Director

Less than half of directors are independent

First half 2022 earnings released: CN¥3.08 loss per share (vs CN¥2.47 loss in 1H 2021)

First half 2022 earnings released: CN¥3.09 loss per share (vs CN¥2.47 loss in 1H 2021)

Hospital Corporation of China Limited to Report Q2, 2022 Results on Aug 30, 2022

Hospital Corporation of China Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended June 30, 2022

Hospital Corporation of China Limited, Annual General Meeting, Jun 22, 2022

Less than half of directors are independent

Full year 2021 earnings released: CN¥2.03 loss per share (vs CN¥2.93 loss in FY 2020)

Hospital Corporation of China Limited Announces Executive Changes

First half 2021 earnings released: CN¥2.47 loss per share (vs CN¥3.87 loss in 1H 2020)

Non Executive Director Zhiqiang Su has left the company

Hospital Corporation of China (HKG:3869) Hasn't Managed To Accelerate Its Returns

Full year 2020 earnings released: CN¥2.93 loss per share (vs CN¥1.09 profit in FY 2019)

Does Hospital Corporation of China (HKG:3869) Have A Healthy Balance Sheet?

Full year 2020 earnings released: CN¥2.93 loss per share (vs CN¥1.09 profit in FY 2019)

Hospital Corporation of China Limited to Report Fiscal Year 2020 Results on Mar 30, 2021

Would Shareholders Who Purchased Hospital Corporation of China's (HKG:3869) Stock Three Years Be Happy With The Share price Today?

New 90-day high: HK$11.38

Hospital Corporation of China Limited Announces Executive Changes

Should You Be Impressed By Hospital Corporation of China's (HKG:3869) Returns on Capital?

New 90-day low: HK$10.60

New 90-day low: HK$10.90

Hospital Corporation of China (HKG:3869) Takes On Some Risk With Its Use Of Debt

Hospital Corporation of China Limited Announces Management Changes

First half earnings released

Hospital Corporation of China Limited to Report First Half, 2020 Results on Aug 28, 2020

CEO

Görev süresi

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş